Drugs / COVID-globulin
Trials 1
| Phase | Registry id | Dates | Indication | Sponsor | Status | Outcome |
|---|---|---|---|---|---|---|
| Phase 2/3 | NCT04842435 | Apr → Sep 2021 | COVID-19 | Microgen | Unknown | No outcome recorded |
Evidence & citations 3 cited values
Every value below carries the sentence it was read from. 1 source stands behind the page.
| Field | Value | Cited text |
|---|---|---|
| Known as | COVID-globulin | ClinicalTrials.gov intervention name — accepted as the source's own label NCT04842435 ↗ |
| Modality | Protein / enzyme biologic | “Anti-coronavirus human immunoglobulin” NCT04842435 ↗ |
| Route | Intravenous | “by intravenous drip” NCT04842435 ↗ |